ELB-031

N/A

Report date: 2022/07/01 15:29:28

Base Information

Drug NameELB-031
Drug Alias NameELB-031
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionAnti-TYRO3 protein tyrosine kinase
TargetsTYRO3 protein tyrosine kinase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesElsalys Biotech
China Registration ClassN/A

Develop Information

Active CompaniesElsalys Biotech
Inactive CompaniesN/A
Active IndicationsNeoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A